Ilmarinen Mutual Pension Insurance Co boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.0% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 163,600 shares of the healthcare conglomerate's stock after purchasing an additional 3,200 shares during the period. UnitedHealth Group comprises about 0.8% of Ilmarinen Mutual Pension Insurance Co's investment portfolio, making the stock its 17th biggest position. Ilmarinen Mutual Pension Insurance Co's holdings in UnitedHealth Group were worth $85,686,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently bought and sold shares of UNH. Brighton Jones LLC increased its stake in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC increased its stake in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares in the last quarter. Gotham Asset Management LLC increased its stake in UnitedHealth Group by 11.8% in the 4th quarter. Gotham Asset Management LLC now owns 18,741 shares of the healthcare conglomerate's stock worth $9,480,000 after buying an additional 1,980 shares in the last quarter. NDVR Inc. increased its stake in UnitedHealth Group by 5.7% in the 4th quarter. NDVR Inc. now owns 681 shares of the healthcare conglomerate's stock worth $344,000 after buying an additional 37 shares in the last quarter. Finally, Morse Asset Management Inc increased its stake in UnitedHealth Group by 2.1% in the 4th quarter. Morse Asset Management Inc now owns 17,964 shares of the healthcare conglomerate's stock worth $9,087,000 after buying an additional 371 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several analysts have commented on UNH shares. JPMorgan Chase & Co. decreased their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research note on Wednesday, August 6th. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Robert W. Baird reissued an "underperform" rating and set a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 20th. Finally, Royal Bank Of Canada reduced their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $355.77.
Get Our Latest Report on UnitedHealth Group
UnitedHealth Group Stock Up 2.1%
UNH stock traded up $7.11 on Thursday, hitting $353.89. 18,916,413 shares of the company's stock were exchanged, compared to its average volume of 19,187,298. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The firm has a 50 day moving average price of $291.11 and a two-hundred day moving average price of $370.48. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $320.51 billion, a P/E ratio of 15.33, a price-to-earnings-growth ratio of 2.27 and a beta of 0.45.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the firm earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's dividend payout ratio is presently 38.30%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.